Arkolith/Insider Trading/TRDA/Form 4

Dowden Nathan J

President & COOEntrada Therapeutics, Inc. (TRDA) · full profile →Form 4 · filed Mar 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$196K
Net Open-Market Flow
-$196K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2026Sell(S)12K$13.05$155K199K
Mar 9, 2026Sell(S)3K$13.02$41K210K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001873392-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML